Investors Sell Shares of UnitedHealth Group (UNH) on Strength Following Insider Selling

Investors sold shares of UnitedHealth Group Inc (NYSE:UNH) on strength during trading hours on Monday following insider selling activity. $98.55 million flowed into the stock on the tick-up and $209.51 million flowed out of the stock on the tick-down, for a money net flow of $110.96 million out of the stock. Of all stocks tracked, UnitedHealth Group had the 0th highest net out-flow for the day. UnitedHealth Group traded up $0.85 for the day and closed at $222.67Specifically, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now directly owns 61,137 shares in the company, valued at approximately $13,652,503.47. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Thomas E. Roos sold 975 shares of the stock in a transaction on Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The disclosure for this sale can be found here. Insiders have sold a total of 34,630 shares of company stock worth $7,669,416 over the last quarter. 0.89% of the stock is currently owned by insiders.

UNH has been the topic of a number of recent research reports. ValuEngine upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Cantor Fitzgerald raised their price target on shares of UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 18th. Wells Fargo & Co restated an “outperform” rating and issued a $245.00 price target (up from $230.00) on shares of UnitedHealth Group in a research report on Wednesday, November 29th. Credit Suisse Group initiated coverage on shares of UnitedHealth Group in a research report on Thursday, November 2nd. They issued an “outperform” rating and a $233.00 price target on the stock. Finally, Royal Bank of Canada raised their price target on shares of UnitedHealth Group to $244.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $224.98.

The firm has a market cap of $215,879.17, a PE ratio of 24.44, a price-to-earnings-growth ratio of 1.65 and a beta of 0.66. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion for the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the firm posted $2.17 EPS. equities analysts forecast that UnitedHealth Group Inc will post 9.99 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st were paid a dividend of $0.75 per share. The ex-dividend date was Thursday, November 30th. This represents a $3.00 annualized dividend and a yield of 1.36%. UnitedHealth Group’s payout ratio is 33.26%.

A number of institutional investors have recently added to or reduced their stakes in the business. Regal Wealth Group Inc. increased its stake in UnitedHealth Group by 0.4% during the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after buying an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. increased its stake in UnitedHealth Group by 0.4% during the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock valued at $204,000 after buying an additional 4 shares during the period. RB Capital Management LLC increased its stake in UnitedHealth Group by 0.4% during the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after buying an additional 7 shares during the period. Highland Private Wealth Management grew its stake in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock worth $593,000 after purchasing an additional 13 shares during the last quarter. Finally, RNC Capital Management LLC grew its stake in shares of UnitedHealth Group by 0.7% in the 2nd quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock worth $360,000 after purchasing an additional 13 shares during the last quarter. 86.01% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Investors Sell Shares of UnitedHealth Group (UNH) on Strength Following Insider Selling” was originally reported by Week Herald and is the sole property of of Week Herald. If you are accessing this article on another site, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The legal version of this article can be read at https://weekherald.com/2017/12/18/traders-sell-shares-of-unitedhealth-group-unh-on-strength-following-insider-selling.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply